Pfizer launches Phase 3 program for JAK1 inhibitor PF-04965842 in atopic dermatitis  Seeking AlphaFull coverage https://seekingalpha.com/news/3318259-pfizer-launches-phase-3-program-jak1-inhibitor-pfminus-04965842-atopic-dermatitis

Advertisements